Kissei Information Disclosure Policy
1. Basic Policy for Information Disclosure
As stated in the Kissei Code of Conduct, the basic policy for information disclosure of Kissei Pharmaceutical Co., Ltd. (“we,” “our,” “the Company”) is to promote communication with shareholders and the broader community and actively and appropriately disclose information, both internally and externally, to enhance the transparency of our corporate activities. To this end, we strive to disclose company information to all stakeholders in a fair, timely, and appropriate manner.
We have also established policy for appropriate information disclosure and dialogue with shareholders in the Kissei Basic Policy on Corporate Governance, and we ensure that such matters are properly addressed.
2. Information Subject to Disclosure
We disclose information in accordance with the Companies Act, the Financial Instrument and Exchange Act, and other relevant laws and regulations, as well as the timely disclosure system based on the rules stipulated by the Tokyo Stock Exchange (TSE), on which we are listed. We also actively disclose information that is not subject to statutory or timely disclosure requirements if we deem such information to have a material impact on investors’ investment decisions.
3. Information Disclosure Methods
We disclose information through the Financial Service Agency’s Electronic Disclosure for Investors’ NETwork (EDINET) and the TSE’s Timely Disclosure Network (TDnet) in accordance with relevant laws and regulations and various rules concerning timely disclosure. We also post such information on the Company website as necessary in consideration of the timeliness and fairness of information disclosure.
We disclose other information in a fair and prompt manner through news releases and by posting it on the Company website in accordance with the purpose of timely disclosure.
4. Quiet Period
To ensure fairness of disclosure and prevent the leak of earnings-related information, we have defined the period from the day following each quarterly closing date to the date of the announcement of the relevant financial results as a quiet period. During such periods, we refrain from making comments on, or responding to questions related to, our account settlement (excluding information that has already been made public). However, if a material fact occurs during a quiet period, such as the possibility of a large discrepancy from the earnings forecast, we will disclose information in an appropriate and timely manner in accordance with the relevant rules of timely disclosure.
5. Disclosure of Forward-Looking Statements
Information that we disclose includes information regarding earnings forecasts and other forward-looking statements. Such disclosures are based on information available at the time of disclosure and may vary greatly from forecasts and projections due to economic conditions, changes in the market environment, revisions to laws and regulations, and the success or failure of research and development.
6. Internal Structure for Information Disclosure
We establish an Information Disclosure Committee, chaired by an information management officer registered with the TSE. The committee conducts deliberations and makes decisions on information disclosure.
7. Fair Disclosure and Prevention of Insider Trading
We establish provisions in our internal rules for basic matters to be observed, such as with respect to the appropriate management of internal information and the trading of shares, and for complying with fair disclosure rules. In these ways, we take appropriate measures for the fair disclosure of material information and the prevention of insider trading.
Established October 1, 2018
